Middle East Pharmaceutical Industries Company (SASE: 4016)
Health Care · Pharmaceuticals · SA
SR63.25
+1.69% today · -15.6% 1Y
Middle East Pharmaceutical Industries Company (SASE: 4016) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $589.61M.
Over the last twelve months the share price has lost 15.6%, trading between 53.89 and 79.09.
Tweenvest scores Middle East Pharmaceutical Industries Company across four factors: quality 82/100, value 73/100, growth 76/100, dividend 59/100. Its strongest factor is quality.
4016 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $589.61M
- Revenue (TTM)
- $136.30M
- P/E
- 20.40
- EPS
- 3.10
- Dividend yield
- 2.19%
- Beta (5Y)
- 0.50
- 52-week high
- SR79.09
- 52-week low
- SR53.89
- Avg volume (3M)
- —
- Shares outstanding
- 35.00M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Jinhe Biotechnology CO., LTD.SZSE: 002688 | $597.95M | CN¥5.30 | +1.92% |
| Beijing Tong Ren Tang Chinese Medicine Company LimitedSEHK: 3613 | $594.15M | HK$5.57 | +0.18% |
| ChengDu ShengNuo Biotec Co.,Ltd.SHSE: 688117 | $593.11M | CN¥18.03 | -2.86% |
| Tibet Weixinkang Medicine Co., Ltd.SHSE: 603676 | $592.53M | CN¥9.18 | +0.99% |
| Hefei Lifeon Pharmaceutical Co., Ltd.SZSE: 003020 | $589.45M | CN¥17.30 | +0.23% |
| Shanghai Xiao Fang Pharmaceutical Co.,Ltd.SHSE: 603207 | $586.98M | CN¥24.47 | +0.04% |
| Huaren Pharmaceutical Co., Ltd.SZSE: 300110 | $584.21M | CN¥3.31 | +4.42% |
| Qianjiang Yongan Pharmaceutical Co., Ltd.SZSE: 002365 | $581.48M | CN¥13.47 | -0.07% |
Figures last refreshed Oct 11, 2026.